Peptides DB
Research-centric peptide and protocol reference hub
Study 25 of 27GHK-Cu literatureNatureTop journal1980

Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells.

Not reported in abstract.

Read at NatureAdd to compare

Where it sits

this study against the rest of the ghk-cu corpus
11
Preclinical · this one
14
Observational
0
Open-label
0
Randomised
2
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
1980

Abstract

The authors’ words, as Nature supplied them

The plasma tripeptide glycyl-L-lysine (GHL), when added at nanomolar concentrations to a wide group of cultured systems, produces a disparate set of responses ranging from the stimulation of growth and differentiation to outright toxicity. Such diverse actions imply that this tripeptide mediates some basic biochemical function common to many types of cells and organisms. During the isolation of GHL we found the compound to co-isolate through a number of steps with approximately equimolar copper and about 1/5 molar iron. Maximal effects on hepatoma cells (HTC4) were seen when the peptide was added with copper and iron to the growth medium. Structure-function studies revealed that several tripeptides with a histidyl-lysyl linkage were nearly as active as GHL. The association of GHL with copper and a homology similarity between the tripeptide and the copper transport sites on albumin and alpha-fetoprotein, where the cupric atom is bound to a histidyl residue adjacent to a basic residue, suggested that GHL may act as a copper transport factor. We report here that the tripeptide readily forms complexes with copper(II) and enhances the uptake of the metal into cultured hepatoma cells.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the GHK-Cu corpus

DGHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.Pharmaceutics · 2026 · Not reported in abstract.reviewDA Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials.Archives of internal medicine research · 2026 · Not reported in abstract.reviewDThe amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I).Science (New York, N.Y.) · 1996—DThe Regenerative Potential of GHK-Cu in Aesthetic Medicine.Aesthetic surgery journal · 2026 · Not reported in abstract.reviewDDefining biomaterial-driven design principles for bioabsorbable flow diverters: current state and perspectives.Bioactive materials · 2026 · Not reported in abstract.reviewCA brain-targeted biomimetic iron-porphyrin covalent organic framework nanoplatform for Alzheimer's disease: synergistic intervention via antioxidant, Aβ-regulating and immunomodulatory effects.Journal of colloid and interface science · 2026 · Copper-ion chelation rate of 41.78%.In vitro